Here is the RIF list - you are at risk if you are on a... 1. "Harvest" product. Little to no investments over the last few years and throwing off cash back to the P&L like Epogen/Aranesp, miscellaneous Oncology (Vectibix, N-Plate etc.). 2. On a product about to go generic and will significantly lose revenue like Sensipar, Neupogen/Neulasta and Enbrel. 3. Experienced (meaning over 50) pharmaceutical/biotechnology Director or Executive Director level at the mid to upper-mid of the the salary ranges. 4. "Hanger-on" supportive role like HR, PR/Corporate Communications, Finance, IS/IT 5. Contrarian view, someone that thinks innovative and internal-entrepreneurial that questions the facts and data versus VP opinion 6. Want a balanced life - working to live vs living to work.
